Xencor | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
AbbVie USD 9.34B 1.36B 2025-03
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amgen USD 5.54B 430M 2025-03
Arrowhead Research 542.71M 715.79M 2025-03
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Cytokinetics -98262000 62.28M 2025-03
GlaxoSmithKline GBP 5.82B 229M 2025-06
J&J USD 14.6B 816M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Xencor 32.73M 77.88M 2025-03


Xencor Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Aug 2025.